In a search for novel antiviral compounds of the 'doubly modified' nucleoside type, we have prepared l-(4-hydroxy-2-oxabutyl)-, l-(4-hydroxy-3-hydroxymethyl-2oxabutyl)-, l-(4-hydroxy-l-hydroxymethyl-2-oxabutyl)-, l-(4-hydroxy-l-methyl-2-oxabutyl), l-(4,5-dihydroxy-2-oxapentyl)-, l-(5-hydroxy-2-oxapentyl), 1-(5hydroxy-l-chloromethyl-2-oxapentyl)-, and l-(6-hydroxy-l-chloromethyl-2-oxahexyl)-2-(trifluoromethylthiomethyl)benzimidazole.
The protected nucleoside analogs (XVIII-XXV) (Table i) were obtained by condensing the trimethylsilyl derivative (IX) (without isolation) with the alkylating agents (X-XVII) in dry acetonitrile, in the presence of an equimolar mixture of trimethylchlorosilane and trifluoromethanesulfonic acid as catalyst. ~F0rmula, next page, below Table i .)
The acetyl groups in the protected derivatives were removed by treatment with methanolic ammonia, to give the unprotected nucleoside analogs (1-VIII) (Tables 1-3).
The PMN spectra of the unprotected nucleoside analogs in DMSO-D~ showed particularly characteristic signals for the hydroxy-groups. For example, the single primary hydroxyl in the spectra of (VI-VIII) appears as a triplet of integral intensity IH. In analogs (I-V), the signals for the hydroxy-groups overlap those for the CH2S methylene protons. The presence of hydroxy-groups in these compounds is shown by the decrease in the integral intensity of the signal at 4.70-4.75 ppm on treating the sample with D20. The CH2 signal in the spectra of (III-V), (VII), (VIII), (XX-XXII), (XXIV), and (XXV) was present as an AB quartet as a result of *The spectra of (I-VIII) were obtained in DMS0-D 6, and of (XVIII-XXV) in CDCI 3. 0nly the most characteristic signals are given; the signals for the benzene ring protons were seen as a multiplet at 7-8 ppm. gThe signal for the primary hydroxy-group overlapped the signal for CH2S. gThe signal for the secondary hydroxy-group overlapped the signal for CH2S.
X, XVIII R=AeOCH2CH~OCH2--; XI, XIX R=AcOCH=CH(CH2OAc)OCH2--; XII, XX R=AeOCH2CH~OCH(CH2OAc)--; XIII, XXI R=AcOCH2CH2OCH(CH3)--; X1V, XXII R=AcOCH2CH(OBz)CH2OCH2--; XV, XXlII R=AcOCH_~CH2CH~OCH2--; XVI. XXlV R=AcOCH2CH~CH~OCH(CH2Cl)--; XVII, XXV R=AcOCH2CH2CH2CH2OCH{CH2CI)-the magnetic nonequivalence of the methylene protons (these protons are diastereotopic). The protons of the I'-CH 2 group in III, V, VII, VIII, XX, XXII, XXIV and (XXV) are diastereotopic in exactly the same way. In compounds (III), (V), (XXI), and (XXII), however, the diasterotopic effect is so small that this signal is present as a broadened singlet, the outer peaks being masked by noise. Only in the spectra of VII, VIII, XX, XXIV and XXV is the I'-CH 2 signal seen as the AB region of an ABX system (two doublets of doublets).
Biological testing showed that in concentrations of 100-200 ~g/kg, compounds (I-III) displayed antiviral activity against a coronavirus (the causative agent of transmissible swine gastroenteritis) and swine enterovirus, the known inhibitor of RNA-viruses 2-(a-hydroxybenzyl)benzimidazole showing a protective effect at concentrations of up to 50 Dg/ml. Test for cytotoxicity showed that (I-III) had no effect on cell morphology at concentrations up to 200 ~g/ ml.
EXPERIMENTAL
UV spectra were obtained on a Specord UV-VIS, and PMR spectra on a Bruker WP-100 SY spectrometer. TLC was carried out on Silufol UV-254 plates in the system chloroform-methanol (9:1). The sorbent used in column chromatography was silica gel L 40/100. The elemental analyses for all the compounds did not differ from the calculated values by more than 2%.
The synthesis of the alkylating agent (X) has been described in [4], (XI) and (XIV) in [5], (XII) in [6] , and (XIII) and (XV-XVIII) in [3].
2-(Trifluoromethylthiomethyl)benzimidazole (XXVI). A mixture of 10.4 g (0.i mole) of o-phenylenediamine and 16.4 g (0.i mmole) of (trifluoromethylthio)-acetic acid [7] in 200 ml of HCI (4 moles/liter) was boiled for 6 h. The mixture was cooled, and neutralized with aqueous ammonia to pH 7. The product was filtered off, dried in vacuo, and recrystallized from benzene to give 16.2 g (70%) of product, mp 164-165~ Hydroxyalkyl Derivatives of 2-(Trifluoromethylthiomethyl)benzimidazole.
To a suspension of 500 mg (2.155 n~nole) of the base in 5 ml of hexamethyldisilazane was added 0.5 ml of trimethylchlorosilane, and the mixture boiled for one hour. The alkylating agent (2.2 mmole) was then added with cooling, followed by 0.28 ml (2.2m mole) of trimethylchlorosilane, 0.19 ml (2.2 mmole) of trifluoromethanesulfonic acid, and I0 ml of dry acetonitrile. The mixture was kept for 24 h at 20~ poured into 50 ml of saturated sodium bicarbonate solution, and extracted with chloroform (3 • 50 ml). The combined extracts were dried over Na2SO 4, and evaporated under reduced pressure. The residue was chromatographed on a 2 • i0 cm column of silica gel, 40-100 ~m, and eluted with a 20% solution of hexane in chloroform. The resulting protected nucleoside was dissolved in half-saturated methanolic armnonia at 0=C, kept for 24 h at 20~ and evaporated under reduced pressure. The residue was chromatographed on a 2 x 6 cm column of silica gel with 5% hexane in chloroform. The resulting unprotected nucleoside was treated with dry ether in the cold, and recrystallized from ethyl acetate-ether (Table I) .
The antiviral activity of the compounds was assessed in a transplanted two-three day culture of swine embryo cells infected with reference standard Purdue transmissible swine gastroenteritis virus, llSth passage, (titer 61g CDTs0/ml) and a vaccine strain of swine enterovirus, Derbyshire (1982) stereotype, 70th passage (81g CDTs0/ml). Antiviral activity was measured by the inhibition of the cytopathic effects of the virus. The dose used was I000 DCTs0 per ml. The test compounds were dissolved in the culture medium (5% blood hydrolyzate) to concentrations of 200, i00, 50, I0, 5, i, and 0.2 Dg/ml. Controls were set up for the cytopathogenic effects of the viruses, the medium without addition of the test compounds, and the toxicity of the test compounds in the absence of viruses. The cytopathogenic effects of the viruses in the controls and in the presence of the test compounds were assessed 24, 48, 96, and 144 h following infection of the cell cultures. i.
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